{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,28]],"date-time":"2026-07-28T05:25:07Z","timestamp":1785216307999,"version":"3.55.0"},"reference-count":87,"publisher":"Oxford University Press (OUP)","issue":"2","license":[{"start":{"date-parts":[[2015,9,1]],"date-time":"2015-09-01T00:00:00Z","timestamp":1441065600000},"content-version":"tdm","delay-in-days":1153,"URL":"http:\/\/doi.wiley.com\/10.1002\/tdm_license_1.1"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2012,8]]},"DOI":"10.1111\/j.1365-2133.2012.10969.x","type":"journal-article","created":{"date-parts":[[2012,3,31]],"date-time":"2012-03-31T11:53:57Z","timestamp":1333194837000},"page":"296-305","source":"Crossref","is-referenced-by-count":118,"title":["Subacute cutaneous lupus erythematosus and its association with drugs: a population-based matched case-control study of 234 patients in Sweden"],"prefix":"10.1093","volume":"167","author":[{"given":"C.M.","family":"Gr\u00f6nhagen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C.M.","family":"Fored","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.","family":"Linder","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"F.","family":"Granath","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"F.","family":"Nyberg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2012,7,5]]},"reference":[{"key":"10.1111\/j.1365-2133.2012.10969.x-BIB1|cit1","doi-asserted-by":"crossref","first-page":"935","DOI":"10.1177\/0961203309106176","article-title":"Drug-induced lupus: an update on its dermatologic aspects","volume":"18","author":"Marzano","year":"2009","journal-title":"Lupus"},{"key":"10.1111\/j.1365-2133.2012.10969.x-BIB2|cit2","doi-asserted-by":"crossref","first-page":"1107","DOI":"10.1177\/0961203310370349","article-title":"Drug-induced subacute cutaneous lupus erythematosus","volume":"19","author":"Callen","year":"2010","journal-title":"Lupus"},{"key":"10.1111\/j.1365-2133.2012.10969.x-BIB3|cit3","first-page":"465","article-title":"A systematic review of drug-induced subacute cutaneous lupus erythematosus","volume":"164","author":"Lowe","year":"2011","journal-title":"Br J Dermatol"},{"key":"10.1111\/j.1365-2133.2012.10969.x-BIB4|cit4","doi-asserted-by":"crossref","first-page":"1409","DOI":"10.1001\/archderm.1979.04010120007006","article-title":"Subacute cutaneous lupus erythematosus: a cutaneous marker for a distinct lupus erythematosus subset","volume":"115","author":"Sontheimer","year":"1979","journal-title":"Arch Dermatol"},{"key":"10.1111\/j.1365-2133.2012.10969.x-BIB5|cit5","doi-asserted-by":"crossref","first-page":"1335","DOI":"10.1111\/j.1365-2133.2011.10272.x","article-title":"Cutaneous lupus erythematosus and the association with systemic lupus erythematosus: a population-based cohort of 1088 patients in Sweden","volume":"164","author":"Gr\u00f6nhagen","year":"2011","journal-title":"Br J Dermatol"},{"key":"10.1111\/j.1365-2133.2012.10969.x-BIB6|cit6","doi-asserted-by":"crossref","first-page":"791","DOI":"10.1001\/archderm.1989.01670180063007","article-title":"Subacute cutaneous lupus erythematosus. Genetic markers and clinical and immunological findings in patients","volume":"125","author":"Johansson-Stephansson","year":"1989","journal-title":"Arch Dermatol"},{"key":"10.1111\/j.1365-2133.2012.10969.x-BIB7|cit7","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1111\/j.1365-2133.2011.10397.x","article-title":"Drug-induced subacute cutaneous lupus erythematosus: evidence for differences from its idiopathic counterpart","volume":"165","author":"Marzano","year":"2011","journal-title":"Br J Dermatol"},{"key":"10.1111\/j.1365-2133.2012.10969.x-BIB8|cit8","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1007\/s12016-007-0031-x","article-title":"Pathophysiology of cutaneous lupus erythematosus","volume":"33","author":"Lin","year":"2007","journal-title":"Clin Rev Allergy Immunol"},{"key":"10.1111\/j.1365-2133.2012.10969.x-BIB9|cit9","doi-asserted-by":"crossref","first-page":"365","DOI":"10.2165\/11310780-000000000-00000","article-title":"Cutaneous lupus erythematosus: issues in diagnosis and treatment","volume":"10","author":"Walling","year":"2009","journal-title":"Am J Clin Dermatol"},{"key":"10.1111\/j.1365-2133.2012.10969.x-BIB10|cit10","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1191\/096120300678828569","article-title":"The spectrum of cutaneous manifestations in lupus erythematosus - the Italian experience","volume":"9","author":"Cardinali","year":"2000","journal-title":"Lupus"},{"key":"10.1111\/j.1365-2133.2012.10969.x-BIB11|cit11","doi-asserted-by":"crossref","first-page":"49","DOI":"10.7326\/0003-4819-103-1-49","article-title":"Subacute cutaneous lupus erythematosus associated with hydrochlorothiazide therapy","volume":"103","author":"Reed","year":"1985","journal-title":"Ann Intern Med"},{"key":"10.1111\/j.1365-2133.2012.10969.x-BIB12|cit12","doi-asserted-by":"crossref","first-page":"S2","DOI":"10.1038\/jid.1993.16","article-title":"Subacute cutaneous lupus erythematosus","volume":"100","author":"David-Bajar","year":"1993","journal-title":"J Invest Dermatol"},{"key":"10.1111\/j.1365-2133.2012.10969.x-BIB13|cit13","doi-asserted-by":"crossref","first-page":"859","DOI":"10.1177\/0961203309103050","article-title":"Chemotherapy-induced subacute lupus erythematosus","volume":"18","author":"Guhl","year":"2009","journal-title":"Lupus"},{"key":"10.1111\/j.1365-2133.2012.10969.x-BIB14|cit14","doi-asserted-by":"crossref","first-page":"1113","DOI":"10.1001\/archdermatol.2010.258","article-title":"Subacute cutaneous lupus erythematosus exacerbated or induced by chemotherapy","volume":"146","author":"Funke","year":"2010","journal-title":"Arch Dermatol"},{"key":"10.1111\/j.1365-2133.2012.10969.x-BIB15|cit15","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1007\/s00403-008-0890-x","article-title":"Drug-induced subacute cutaneous lupus erythematosus: a paradigm for bedside-to-bench patient-oriented translational clinical investigation","volume":"301","author":"Sontheimer","year":"2009","journal-title":"Arch Dermatol Res"},{"key":"10.1111\/j.1365-2133.2012.10969.x-BIB16|cit16","doi-asserted-by":"crossref","first-page":"357","DOI":"10.2165\/11588500-000000000-00000","article-title":"Drug-induced lupus erythematosus: incidence, management and prevention","volume":"34","author":"Chang","year":"2011","journal-title":"Drug Saf"},{"key":"10.1111\/j.1365-2133.2012.10969.x-BIB17|cit17","volume-title":"Kodningskvalitet i Patientregistret - Slutenv\u00e5rd 2007","author":"Socialstyrelsen","year":"2009"},{"key":"10.1111\/j.1365-2133.2012.10969.x-BIB18|cit18","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1080\/03009740252937568","article-title":"Increased cancer incidence in a Swedish cohort of patients with systemic lupus erythematosus","volume":"31","author":"Bjornadal","year":"2002","journal-title":"Scand J Rheumatol"},{"key":"10.1111\/j.1365-2133.2012.10969.x-BIB19|cit19","doi-asserted-by":"crossref","first-page":"2341","DOI":"10.1093\/humrep\/dep186","article-title":"Endometriosis, assisted reproduction technology, and risk of adverse pregnancy outcome","volume":"24","author":"Stephansson","year":"2009","journal-title":"Hum Reprod"},{"key":"10.1111\/j.1365-2133.2012.10969.x-BIB20|cit20","volume-title":"Kvalitet och Inneh\u00e5ll i Patientregistret: Utskrivningar fr\u00e5n Slutenv\u00e5rden 1964-2007 och Bes\u00f6k i Specialiserad \u00d6ppenv\u00e5rd (Exklusive Prim\u00e4rv\u00e5rdsbes\u00f6k) 1997-2007","author":"Socialstyrelsen","year":"2009"},{"key":"10.1111\/j.1365-2133.2012.10969.x-BIB21|cit21","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1080\/02841860802247664","article-title":"The completeness of the Swedish Cancer Register: a sample survey for year 1998","volume":"48","author":"Barlow","year":"2009","journal-title":"Acta Oncol"},{"key":"10.1111\/j.1365-2133.2012.10969.x-BIB22|cit22","first-page":"598","article-title":"[Reliability of the hospital registry. The diagnostic data are better than their reputation]","volume":"91","author":"Nilsson","year":"1994","journal-title":"Lakartidningen"},{"key":"10.1111\/j.1365-2133.2012.10969.x-BIB23|cit23","volume-title":"Official Statistics of Sweden, Pharmaceuticals - Statistics for 2010","author":"Swedish National Board of Health and Welfare","year":"2011"},{"key":"10.1111\/j.1365-2133.2012.10969.x-BIB24|cit24","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1080\/00031305.1989.10475597","article-title":"Median unbiased estimation for binary data","volume":"43","author":"Hirji","year":"1989","journal-title":"Am Stat"},{"key":"10.1111\/j.1365-2133.2012.10969.x-BIB25|cit25","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1093\/oxfordjournals.epirev.a036144","article-title":"Attributable risk estimation in case-control studies","volume":"16","author":"Coughlin","year":"1994","journal-title":"Epidemiol Rev"},{"key":"10.1111\/j.1365-2133.2012.10969.x-BIB26|cit26","doi-asserted-by":"crossref","first-page":"e403","DOI":"10.1111\/j.1365-2230.2009.03380.x","article-title":"Subacute cutaneous lupus erythematosus associated with terbinafine","volume":"34","author":"Kasperkiewicz","year":"2009","journal-title":"Clin Exp Dermatol"},{"key":"10.1111\/j.1365-2133.2012.10969.x-BIB27|cit27","doi-asserted-by":"crossref","first-page":"823","DOI":"10.1111\/j.1610-0387.2008.06806.x","article-title":"Subacute cutaneous lupus erythematosus induced by terbinafine: case report and review of literature","volume":"6","author":"Lorentz","year":"2008","journal-title":"J Dtsch Dermatol Ges"},{"key":"10.1111\/j.1365-2133.2012.10969.x-BIB28|cit28","doi-asserted-by":"crossref","first-page":"8","DOI":"10.3109\/03009742.2010.493895","article-title":"Small-area variations in sales of TNF inhibitors in Sweden between 2000 and 2009","volume":"40","author":"Neovius","year":"2011","journal-title":"Scand J Rheumatol"},{"issue":"Suppl.","key":"10.1111\/j.1365-2133.2012.10969.x-BIB29|cit29","doi-asserted-by":"crossref","first-page":"S114","DOI":"10.1016\/j.jaad.2007.01.040","article-title":"Drug-induced lupus erythematosus in a patient treated with adalimumab","volume":"56","author":"Spillane","year":"2007","journal-title":"J Am Acad Dermatol"},{"key":"10.1111\/j.1365-2133.2012.10969.x-BIB30|cit30","doi-asserted-by":"crossref","first-page":"676","DOI":"10.1177\/0961203307088291","article-title":"Adalimumab-induced lupus erythematosus","volume":"17","author":"Martin","year":"2008","journal-title":"Lupus"},{"key":"10.1111\/j.1365-2133.2012.10969.x-BIB31|cit31","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1177\/096120339700600204","article-title":"Epidemiology and socioeconomic impact of skin disease in lupus erythematosus","volume":"6","author":"Tebbe","year":"1997","journal-title":"Lupus"},{"key":"10.1111\/j.1365-2133.2012.10969.x-BIB32|cit32","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1007\/s00403-008-0895-5","article-title":"Drug-induced lupus erythematosus","volume":"301","author":"Vedove","year":"2009","journal-title":"Arch Dermatol Res"},{"key":"10.1111\/j.1365-2133.2012.10969.x-BIB33|cit33","doi-asserted-by":"crossref","first-page":"1089","DOI":"10.1093\/rheumatology\/36.10.1089","article-title":"Predisposing factors in sulphasalazine-induced systemic lupus erythematosus","volume":"36","author":"Gunnarsson","year":"1997","journal-title":"Br J Rheumatol"},{"key":"10.1111\/j.1365-2133.2012.10969.x-BIB34|cit34","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1001\/archderm.139.1.45","article-title":"Drug-induced, Ro\/SSA-positive cutaneous lupus erythematosus","volume":"139","author":"Srivastava","year":"2003","journal-title":"Arch Dermatol"},{"key":"10.1111\/j.1365-2133.2012.10969.x-BIB35|cit35","doi-asserted-by":"crossref","first-page":"2240","DOI":"10.1001\/archinte.162.19.2240","article-title":"Ticlopidine-induced lupus: a report of 4 cases","volume":"162","author":"Spiera","year":"2002","journal-title":"Arch Intern Med"},{"key":"10.1111\/j.1365-2133.2012.10969.x-BIB36|cit36","doi-asserted-by":"crossref","first-page":"1112","DOI":"10.1111\/j.1365-4632.2006.02783.x","article-title":"Drug-induced subacute cutaneous lupus erythematosus resulting from ticlopidine","volume":"45","author":"Reich","year":"2006","journal-title":"Int J Dermatol"},{"key":"10.1111\/j.1365-2133.2012.10969.x-BIB37|cit37","doi-asserted-by":"crossref","first-page":"588","DOI":"10.1111\/j.1365-2125.2010.03733.x","article-title":"Do selected drugs increase the risk of lupus? A matched case-control study","volume":"70","author":"Schoonen","year":"2010","journal-title":"Br J Clin Pharmacol"},{"key":"10.1111\/j.1365-2133.2012.10969.x-BIB38|cit38","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1016\/j.autrev.2005.01.002","article-title":"Current trends in drug-induced autoimmunity","volume":"4","author":"Uetrecht","year":"2005","journal-title":"Autoimmun Rev"},{"key":"10.1111\/j.1365-2133.2012.10969.x-BIB39|cit39","doi-asserted-by":"crossref","first-page":"1526","DOI":"10.1056\/NEJMoa021933","article-title":"Development of autoantibodies before the clinical onset of systemic lupus erythematosus","volume":"349","author":"Arbuckle","year":"2003","journal-title":"N Engl J Med"},{"key":"10.1111\/j.1365-2133.2012.10969.x-BIB40|cit40","doi-asserted-by":"crossref","first-page":"733","DOI":"10.1111\/j.1365-2230.2008.03105.x","article-title":"Lansoprazole-induced subacute cutaneous lupus erythematosus","volume":"34","author":"Panting","year":"2009","journal-title":"Clin Exp Dermatol"},{"key":"10.1111\/j.1365-2133.2012.10969.x-BIB41|cit41","first-page":"100","article-title":"Subacute cutaneous lupus erythematosus-like eruption caused by hydrochlorothiazide","volume":"6","author":"Parodi","year":"1989","journal-title":"Photodermatology"},{"key":"10.1111\/j.1365-2133.2012.10969.x-BIB42|cit42","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1016\/S0190-9622(88)70005-5","article-title":"Subacute cutaneous lupus erythematosus-like drug eruption due to combination diuretic hydrochlorothiazide and triamterene","volume":"18","author":"Darken","year":"1988","journal-title":"J Am Acad Dermatol"},{"key":"10.1111\/j.1365-2133.2012.10969.x-BIB43|cit43","doi-asserted-by":"crossref","first-page":"729","DOI":"10.3109\/15563659509010639","article-title":"Thiazide diuretics induce cutaneous lupus-like adverse reaction","volume":"33","author":"Brown","year":"1995","journal-title":"J Toxicol Clin Toxicol"},{"key":"10.1111\/j.1365-2133.2012.10969.x-BIB44|cit44","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1111\/j.1365-2230.1979.tb01595.x","article-title":"A distinctive eruption in patients receiving oxprenolol","volume":"4","author":"Gange","year":"1979","journal-title":"Clin Exp Dermatol"},{"key":"10.1111\/j.1365-2133.2012.10969.x-BIB45|cit45","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1159\/000086668","article-title":"Acebutolol-induced subacute cutaneous lupus erythematosus","volume":"18","author":"Fenniche","year":"2005","journal-title":"Skin Pharmacol Physiol"},{"key":"10.1111\/j.1365-2133.2012.10969.x-BIB46|cit46","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1016\/S0046-8177(97)90281-1","article-title":"Subacute cutaneous lupus erythematosus arising in the setting of calcium channel blocker therapy","volume":"28","author":"Crowson","year":"1997","journal-title":"Hum Pathol"},{"key":"10.1111\/j.1365-2133.2012.10969.x-BIB47|cit47","doi-asserted-by":"crossref","first-page":"1429","DOI":"10.1056\/NEJM199511233332117","article-title":"Diltiazem and subacute cutaneous lupus erythematosus-like lesions","volume":"333","author":"Crowson","year":"1995","journal-title":"N Engl J Med"},{"key":"10.1111\/j.1365-2133.2012.10969.x-BIB48|cit48","first-page":"506","article-title":"Case report: verapamil-induced subacute cutaneous lupus erythematosus","volume":"4","author":"Kurtis","year":"2005","journal-title":"J Drugs Dermatol"},{"key":"10.1111\/j.1365-2133.2012.10969.x-BIB49|cit49","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1007\/s10227-002-0122-5","article-title":"Subacute cutaneous lupus erythematosus induced by nifedipine","volume":"7","author":"Gubinelli","year":"2003","journal-title":"J Cutan Med Surg"},{"key":"10.1111\/j.1365-2133.2012.10969.x-BIB50|cit50","first-page":"213","article-title":"Nitrendipine-induced subacute cutaneous lupus erythematosus","volume":"13","author":"Marzano","year":"2003","journal-title":"Eur J Dermatol"},{"key":"10.1111\/j.1365-2133.2012.10969.x-BIB51|cit51","doi-asserted-by":"crossref","first-page":"447","DOI":"10.2340\/0001555565447448","article-title":"Lupus erythematosus-like eruption from captopril","volume":"65","author":"Patri","year":"1985","journal-title":"Acta Derm Venereol (Stockh)"},{"key":"10.1111\/j.1365-2133.2012.10969.x-BIB52|cit52","doi-asserted-by":"crossref","first-page":"398","DOI":"10.1016\/S0140-6736(95)90392-5","article-title":"Subacute cutaneous lupus erythematosus associated with cilazapril","volume":"345","author":"Fernandez-Diaz","year":"1995","journal-title":"Lancet"},{"key":"10.1111\/j.1365-2133.2012.10969.x-BIB53|cit53","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1159\/000077320","article-title":"Lupus-like syndrome associated with statin therapy","volume":"208","author":"Noel","year":"2004","journal-title":"Dermatology"},{"key":"10.1111\/j.1365-2133.2012.10969.x-BIB54|cit54","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1111\/j.1365-2230.2007.02488.x","article-title":"Statin-induced Ro\/SSa-positive subacute cutaneous lupus erythematosus","volume":"32","author":"Suchak","year":"2007","journal-title":"Clin Exp Dermatol"},{"key":"10.1111\/j.1365-2133.2012.10969.x-BIB55|cit55","first-page":"353","article-title":"Lansoprazole-induced subacute cutaneous lupus erythematosus: two cases","volume":"85","author":"Bracke","year":"2005","journal-title":"Acta Derm Venereol (Stockh)"},{"key":"10.1111\/j.1365-2133.2012.10969.x-BIB56|cit56","doi-asserted-by":"crossref","first-page":"87","DOI":"10.2340\/00015555-0335","article-title":"Subacute cutaneous lupus erythematosus induced or exacerbated by proton pump inhibitors","volume":"88","author":"Dam","year":"2008","journal-title":"Acta Derm Venereol (Stockh)"},{"key":"10.1111\/j.1365-2133.2012.10969.x-BIB57|cit57","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1111\/j.1365-2230.2010.03926.x","article-title":"Drug-induced subacute cutaneous lupus erythematosus associated with omeprazole","volume":"36","author":"Toms-Whittle","year":"2011","journal-title":"Clin Exp Dermatol"},{"key":"10.1111\/j.1365-2133.2012.10969.x-BIB58|cit58","doi-asserted-by":"crossref","first-page":"e1","DOI":"10.1111\/j.1365-2230.2008.03125.x","article-title":"Omeprazole-induced subacute cutaneous lupus erythematosus","volume":"35","author":"Mankia","year":"2010","journal-title":"Clin Exp Dermatol"},{"key":"10.1111\/j.1365-2133.2012.10969.x-BIB59|cit59","doi-asserted-by":"crossref","first-page":"370","DOI":"10.2340\/00015555-0473","article-title":"Clinical follow-up of 102 anti-Ro\/SSA-positive patients with dermatological manifestations","volume":"88","author":"Popovic","year":"2008","journal-title":"Acta Derm Venereol (Stockh)"},{"key":"10.1111\/j.1365-2133.2012.10969.x-BIB60|cit60","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1159\/000247739","article-title":"Systemic lupus erythematosus exacerbated by piroxicam","volume":"182","author":"Roura","year":"1991","journal-title":"Dermatologica"},{"key":"10.1111\/j.1365-2133.2012.10969.x-BIB61|cit61","first-page":"156","article-title":"Terbinafine-induced subacute cutaneous lupus erythematosus","volume":"81","author":"Hivnor","year":"2008","journal-title":"Cutis"},{"key":"10.1111\/j.1365-2133.2012.10969.x-BIB62|cit62","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1016\/S0190-9622(89)80031-3","article-title":"Subacute cutaneous lupus erythematosus lesions precipitated by griseofulvin","volume":"21","author":"Miyagawa","year":"1989","journal-title":"J Am Acad Dermatol"},{"key":"10.1111\/j.1365-2133.2012.10969.x-BIB63|cit63","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1001\/archderm.141.1.103","article-title":"Ro\/SSA-positive cutaneous lupus erythematosus induced by carbamazepine","volume":"141","author":"Capponi","year":"2005","journal-title":"Arch Dermatol"},{"key":"10.1111\/j.1365-2133.2012.10969.x-BIB64|cit64","first-page":"281","article-title":"Drug-induced cutaneous lupus erythematosus after 5\u2003years of treatment with carbamazepine","volume":"16","author":"Amerio","year":"2006","journal-title":"Eur J Dermatol"},{"key":"10.1111\/j.1365-2133.2012.10969.x-BIB65|cit65","doi-asserted-by":"crossref","first-page":"474","DOI":"10.1046\/j.1365-2230.2002.01107.x","article-title":"Subacute cutaneous lupus erythematosus associated with phenytoin","volume":"27","author":"Ross","year":"2002","journal-title":"Clin Exp Dermatol"},{"key":"10.1111\/j.1365-2133.2012.10969.x-BIB66|cit66","doi-asserted-by":"crossref","first-page":"1317","DOI":"10.1093\/rheumatology\/40.11.1317","article-title":"Etanercept-induced subacute cutaneous lupus erythematosus","volume":"40","author":"Bleumink","year":"2001","journal-title":"Rheumatology (Oxford)"},{"key":"10.1111\/j.1365-2133.2012.10969.x-BIB67|cit67","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1111\/j.1365-4632.2011.04871.x","article-title":"TNF alpha antagonist-induced lupus-like syndrome: report and review of the literature with implications for treatment with alternative TNF alpha antagonists","volume":"50","author":"Williams","year":"2011","journal-title":"Int J Dermatol"},{"issue":"Suppl.","key":"10.1111\/j.1365-2133.2012.10969.x-BIB68|cit68","doi-asserted-by":"crossref","first-page":"S242","DOI":"10.1016\/j.jaad.2005.10.037","article-title":"Efalizumab-induced subacute cutaneous lupus erythematosus","volume":"54","author":"Bentley","year":"2006","journal-title":"J Am Acad Dermatol"},{"key":"10.1111\/j.1365-2133.2012.10969.x-BIB69|cit69","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1111\/j.1365-2230.2007.02503.x","article-title":"Adalimumab-induced cutaneous lupus","volume":"32","author":"Sheth","year":"2007","journal-title":"Clin Exp Dermatol"},{"key":"10.1111\/j.1365-2133.2012.10969.x-BIB70|cit70","first-page":"818","article-title":"Docetaxel (taxotere) induced subacute cutaneous lupus erythematosus: report of 4 cases","volume":"31","author":"Chen","year":"2004","journal-title":"J Rheumatol"},{"key":"10.1111\/j.1365-2133.2012.10969.x-BIB71|cit71","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1111\/j.1346-8138.2007.00313.x","article-title":"Paclitaxel-induced cutaneous lupus erythematosus in patients with serum anti-SSA\/Ro antibody","volume":"34","author":"Adachi","year":"2007","journal-title":"J Dermatol"},{"key":"10.1111\/j.1365-2133.2012.10969.x-BIB72|cit72","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1159\/000083798","article-title":"Subacute cutaneous lupus erythematosus associated with tamoxifen therapy: two cases","volume":"210","author":"Fumal","year":"2005","journal-title":"Dermatology"},{"key":"10.1111\/j.1365-2133.2012.10969.x-BIB73|cit73","doi-asserted-by":"crossref","first-page":"340","DOI":"10.1001\/archdermatol.2008.619","article-title":"Subacute cutaneous lupus erythematosus associated with capecitabine monotherapy","volume":"145","author":"Fernandes","year":"2009","journal-title":"Arch Dermatol"},{"issue":"Suppl. 1","key":"10.1111\/j.1365-2133.2012.10969.x-BIB74|cit74","doi-asserted-by":"crossref","first-page":"S4","DOI":"10.1016\/j.jaad.2007.06.040","article-title":"Occurrence of subacute cutaneous lupus erythematosus after treatment with fluorouracil and capecitabine","volume":"59","author":"Weger","year":"2008","journal-title":"J Am Acad Dermatol"},{"key":"10.1111\/j.1365-2133.2012.10969.x-BIB75|cit75","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1177\/0961203307087189","article-title":"Leflunomide-induced subacute cutaneous lupus erythematosus with erythema multiforme-like lesions","volume":"17","author":"Marzano","year":"2008","journal-title":"Lupus"},{"key":"10.1111\/j.1365-2133.2012.10969.x-BIB76|cit76","doi-asserted-by":"crossref","first-page":"724","DOI":"10.1111\/j.1365-2230.2005.01898.x","article-title":"Subacute cutaneous lupus erythematosus precipitated by leflunomide","volume":"30","author":"Chan","year":"2005","journal-title":"Clin Exp Dermatol"},{"key":"10.1111\/j.1365-2133.2012.10969.x-BIB77|cit77","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1111\/j.1365-2230.2004.01527.x","article-title":"Subacute cutaneous lupus erythematosus associated with leflunomide","volume":"29","author":"Kerr","year":"2004","journal-title":"Clin Exp Dermatol"},{"key":"10.1111\/j.1365-2133.2012.10969.x-BIB78|cit78","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1136\/ard.2003.019323","article-title":"Lupus erythematosus with leflunomide: induction or reactivation?","volume":"64","author":"Gensburger","year":"2005","journal-title":"Ann Rheum Dis"},{"key":"10.1111\/j.1365-2133.2012.10969.x-BIB79|cit79","doi-asserted-by":"crossref","first-page":"823","DOI":"10.1093\/rheumatology\/keh586","article-title":"Leflunomide-induced subacute cutaneous lupus erythematosus","volume":"44","author":"Goeb","year":"2005","journal-title":"Rheumatology (Oxford)"},{"key":"10.1111\/j.1365-2133.2012.10969.x-BIB80|cit80","first-page":"189","article-title":"Subacute cutaneous lupus erythematosus associated with leflunomide","volume":"76","author":"Elias","year":"2005","journal-title":"Cutis"},{"key":"10.1111\/j.1365-2133.2012.10969.x-BIB81|cit81","doi-asserted-by":"crossref","first-page":"1825","DOI":"10.1016\/S0140-6736(05)79887-1","article-title":"Subacute cutaneous lupus erythematosus associated with interferon beta-1a","volume":"352","author":"Nousari","year":"1998","journal-title":"Lancet"},{"key":"10.1111\/j.1365-2133.2012.10969.x-BIB82|cit82","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1111\/j.1365-2133.2008.08587.x","article-title":"Subacute cutaneous lupus erythematosus in a leuprorelin-treated patient with prostate carcinoma","volume":"159","author":"Wiechert","year":"2008","journal-title":"Br J Dermatol"},{"key":"10.1111\/j.1365-2133.2012.10969.x-BIB83|cit83","doi-asserted-by":"crossref","first-page":"628","DOI":"10.1111\/j.1365-2133.2007.08367.x","article-title":"Anastrozole-induced subacute cutaneous lupus erythematosus","volume":"158","author":"Trancart","year":"2008","journal-title":"Br J Dermatol"},{"key":"10.1111\/j.1365-2133.2012.10969.x-BIB84|cit84","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1111\/j.1600-0560.1999.tb01809.x","article-title":"Lichenoid and subacute cutaneous lupus erythematosus-like dermatitis associated with antihistamine therapy","volume":"26","author":"Crowson","year":"1999","journal-title":"J Cutan Pathol"},{"key":"10.1111\/j.1365-2133.2012.10969.x-BIB85|cit85","doi-asserted-by":"crossref","first-page":"364","DOI":"10.1191\/096120398678920244","article-title":"Subacute cutaneous lupus erythematosus associated with cinnarizine and thiethylperazine therapy","volume":"7","author":"Toll","year":"1998","journal-title":"Lupus"},{"key":"10.1111\/j.1365-2133.2012.10969.x-BIB86|cit86","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1111\/j.1440-0960.2005.00199.x","article-title":"Bupropion-induced subacute cutaneous lupus erythematosus","volume":"46","author":"Cassis","year":"2005","journal-title":"Australas J Dermatol"},{"key":"10.1111\/j.1365-2133.2012.10969.x-BIB87|cit87","doi-asserted-by":"crossref","first-page":"911","DOI":"10.1001\/archderm.141.7.911","article-title":"Inhalation route inducing subacute cutaneous lupus erythematosus with tiotropium","volume":"141","author":"Pham","year":"2005","journal-title":"Arch Dermatol"}],"container-title":["British Journal of Dermatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1365-2133.2012.10969.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/onlinelibrary.wiley.com\/wol1\/doi\/10.1111\/j.1365-2133.2012.10969.x\/fullpdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,4,22]],"date-time":"2024-04-22T13:29:50Z","timestamp":1713792590000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/bjd\/article\/167\/2\/296\/6614066"}},"subtitle":["SCLE and its association with drugs"],"short-title":[],"issued":{"date-parts":[[2012,7,5]]},"references-count":87,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2012,8]]}},"URL":"https:\/\/doi.org\/10.1111\/j.1365-2133.2012.10969.x","relation":{},"ISSN":["0007-0963"],"issn-type":[{"value":"0007-0963","type":"print"}],"subject":[],"published":{"date-parts":[[2012,7,5]]}}}